Completed PHASE4 INTERVENTIONAL 4-arm NCT04773886

Effectiveness of Mineral Trioxide Aggregate and Platelet Rich Fibrin Along With Biodentine. .

To Evaluate the Effectiveness of Mineral Trioxide Aggregate and Platelet Rich Fibrin Along With Biodentine as Pulpotomy Medicament in Patients With Pulpitis.

Sponsor: Maharishi Markendeswar University (Deemed to be University)

Conditions Pulpitis - Irreversible

Interventions Biodentine Mineral trioxide aggregate Platelet rich fibrin

Updated 4 times since 2021 Last updated: Mar 13, 2021 Started: Feb 1, 2020 Primary completion: Mar 12, 2021 Completion: Mar 12, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Pulpitis - Irreversible, this trial is completed. The trial is conducted by Maharishi Markendeswar University (Deemed to be University) and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Mar 2021 — Apr 2021 [monthly]

Recruiting PHASE4

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maharishi Markendeswar University (Deemed to be University)

Data source: Maharishi Markendeswar University (Deemed to be University)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ambāla, India